JESSICA WOLFE: Open Payments
NPI 1649943689 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 26 payments from 10 companies in 2025. Trend: 2023 $539 · 2024 $456 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $177 |
| Lilly USA, LLC | 9 | $152 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| ABBVIE INC. | 3 | $51 |
| UCB, Inc. | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $15 |
| Boston Scientific Corporation | 1 | $14 |
| Organon LLC | 1 | $6 |
Products named: WAYRILZ, TALTZ, Bimzelx, Rhapsido, EBGLYSS, DUPIXENT, SPEVIGO, COSENTYX.
Industry payments across IA — which companies pay providers there.
